GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » 5-Year Yield-on-Cost %

Australian Clinical Labs (ASX:ACL) 5-Year Yield-on-Cost % : 4.39 (As of Jul. 22, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs 5-Year Yield-on-Cost %?

Australian Clinical Labs's yield on cost for the quarter that ended in Dec. 2024 was 4.39.


The historical rank and industry rank for Australian Clinical Labs's 5-Year Yield-on-Cost % or its related term are showing as below:

ASX:ACL' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 2.26   Med: 3.62   Max: 21.72
Current: 4.39


During the past 5 years, Australian Clinical Labs's highest Yield on Cost was 21.72. The lowest was 2.26. And the median was 3.62.


ASX:ACL's 5-Year Yield-on-Cost % is ranked better than
75% of 64 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.9 vs ASX:ACL: 4.39

Competitive Comparison of Australian Clinical Labs's 5-Year Yield-on-Cost %

For the Diagnostics & Research subindustry, Australian Clinical Labs's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Australian Clinical Labs's 5-Year Yield-on-Cost % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Australian Clinical Labs's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Australian Clinical Labs's 5-Year Yield-on-Cost % falls into.


;
;

Australian Clinical Labs 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Australian Clinical Labs is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Australian Clinical Labs  (ASX:ACL) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Australian Clinical Labs 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Australian Clinical Labs Business Description

Traded in Other Exchanges
N/A
Address
1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168
Australian Clinical Labs is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well established in the states of Western Australia, South Australia, Victoria, and the Northern Territory.

Australian Clinical Labs Headlines

No Headlines